Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
- Daniel H. Palmer
- , Richard Jackson
- , Christoph Springfeld
- , Paula Ghaneh
- , Charlotte Rawcliffe
- , Christopher M. Halloran
- , Olusola Faluyi
- , David Cunningham
- , Jonathan Wadsley
- , Suzanne Darby
- , Tim Meyer
- , Roopinder Gillmore
- , Pehr Lind
- , Bengt Glimelius
- , Stephen Falk
- , Yuk Ting Ma
- , Gary William Middleton
- , Sebastian Cummins
- , Paul J. Ross
- , Harpreet Wasan
- University of Liverpool
- Heidelberg University
- Champalimaud Foundation
- Clatterbridge Cancer Centre NHS Foundation Trust
- Royal Marsden NHS Foundation Trust
- Sheffield Teaching Hospitals NHS Foundation Trust
- University College London
- Royal Free London NHS Foundation Trust
- Stockholm County Council
- Karolinska Institutet
- Uppsala University
- Bristol Cancer Institute
- University Hospitals Birmingham NHS Foundation Trust
- Royal Surrey County Hospital NHS Foundation Trust
- Guy's and St Thomas' NHS Foundation Trust
- Imperial College Healthcare NHS Trust
- Beatson Oncology Centre
- Velindre University NHS Trust
- Université Paris-Saclay
- Lund University
- University Hospitals Coventry and Warwickshire NHS Trust
- Cholangiocarcinoma Foundation
- German Cancer Research Center
- Technical University of Munich
- University of Hamburg
Research output: Contribution to journal › Article › peer-review
40
Citations
(Scopus)